Pharma Journalist -

Biohaven Pharmaceutical Holding Company Ltd. reported negative topline results from its Phase 3 clinical trial evaluating troriluzole compared to placebo for the treatment of patients…
Read More...

Eli Lilly and Company announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study showed…
Read More...

Kite, a Gilead Company announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted Priority Review designation for…
Read More...

SMi Reports: The AI in Drug Discovery conference will feature a panel discussion with panellists from Novartis, OMass Therapeutics, Domaineux and AstraZeneca. SMi Group’s inaugural AI…
Read More...

With just three weeks until the RAS- Targeted Drug Discovery Summit Europe, don’t miss this unique opportunity to present your research to 80+ attendees from Europe’s large pharma and…
Read More...

BOSTON, January 2020 – Hansonwade will present the 4th NASH Summit in Boston from May 4-7, 2020. For its anticipated return, the forum is set to widen its program and congregate over…
Read More...

SMi reports: The Highly Potent Active Pharmaceutical Ingredients conference will explore real-world examples of PBD payload synthesis, manufacture of oncology products and design of ADC…
Read More...

The Vegetation Management business within Bayer CropScience LP, announces the label for its latest product. Invora Herbicide has received federal approval from the U.S. Environmental…
Read More...

Pelican BioThermal, the global name in temperature-controlled packaging, today announces the acquisition of NanoCool, an Albuquerque, New Mexico-based manufacturer of…
Read More...

Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, and Bormioli Pharma announce today a collaboration agreement. The agreement…
Read More...